InsiderClue
← All stocks

Veraxa Biotech AG - Post de-SPAC

VRXA Net buying
CIK 0002079109 #3703 in the set updated 17 Sep 2026
Bought (1 mo)
$82.65K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$82.65K
+$82.65K against sales at will

By person

2 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baumann Oliver Rolf
Director
$75.00K (1)
—
+$75.00K
5,773,618
$8.83M
+0.9%
Antz Christoph Rudiger
Chief Executive Officer
$7.65K (1)
—
+$7.65K
5,000
$7.65K
—

No percentages here. Veraxa Biotech AG - Post de-SPAC reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Antz Christoph Rudiger
27 Aug 2026
Chief Executive Officer
Buy
5,000
$1.53
$7.65K
Baumann Oliver Rolf
27 Aug 2026
Director
Buy indirect
50,000
$1.50
$75.00K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Aug 2026